Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L1DP
|
||||
Former ID |
DCL000675
|
||||
Drug Name |
ABT-089
|
||||
Synonyms |
Pozanicline; A 94224; ABT 089; Pozanicline (USAN); (R)-2-Methyl-3-(2-pyrrolidinylmethoxy)pyridine; 2-Methyl-3-(2-pyrrolidinylmethoxy)pyridine; 2-Methyl-3-(2S-pyrrolidinylmethoxy)pyridine; 2-methyl-3-[[(2R)-pyrrolidin-2-yl]methoxy]pyridine; 2-methyl-3-[[(2S)-pyrrolidin-2-yl]methoxy]pyridine
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Attention deficit hyperactivity disorder; Schizophrenia; Anxiety; Dementia [ICD9: 290-294, 295, 300, 314.0; ICD10:F01-F07, F20, F40-F42, F90] | Discontinued in Phase 2 | [536499] | ||
Company |
Abbott Laboratories
|
||||
Structure |
Download2D MOL |
||||
Formula |
C11H16N2O
|
||||
Canonical SMILES |
CC1=C(C=CC=N1)OCC2CCCN2
|
||||
InChI |
1S/C11H16N2O/c1-9-11(5-3-6-12-9)14-8-10-4-2-7-13-10/h3,5-6,10,13H,2,4,7-8H2,1H3/t10-/m0/s1
|
||||
InChIKey |
YRVIKLBSVVNSHF-JTQLQIEISA-N
|
||||
CAS Number |
CAS 161417-03-4
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Nicotinic ACh receptor alpha 4/beta 2 | Target Info | Modulator | ||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.